A Relative Cost of Control Analysis of Once-Weekly Semaglutide Versus Exenatide Extended-Release and Dulaglutide for Bringing Patients to HbA1c and Weight Loss Treatment Targets in the USA.

Name: A Relative Cost of Control Analysis of Once-Weekly Semaglutide Versus Exenatide Extended-Release and Dulaglutide for Bringing Patients to HbA1c and Weight Loss Treatment Targets in the USA.
Author: Johansen, Pierre

A Relative Cost of Control Analysis of Once-Weekly Semaglutide Versus Exenatide Extended-Release and Dulaglutide for Bringing Patients to HbA1c and Weight Loss Treatment Targets in the USA. — المؤلف: Johansen, Pierre — Advances in therapy 20200506

المؤلف: Johansen, Pierre
النشر: Advances in therapy 20200506
الوصف: 1190-1199 p.
الموضوعات: Body Weight؛ Diabetes Mellitus, Type 2؛ Drug Administration Schedule؛ Exenatide؛ Female؛ Glucagon-Like Peptides؛ Glycated Hemoglobin؛ Humans